This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Incidence of Benign and Malignant Neoplasms in Crohn's Disease Patients Aged ≤30 Years Versus 30‐64 Years Treated With Certolizumab Pegol: Results From a Pooled Safety Analysis of 15 Studies: 1831. (October 2015)
Record Type:
Journal Article
Title:
Incidence of Benign and Malignant Neoplasms in Crohn's Disease Patients Aged ≤30 Years Versus 30‐64 Years Treated With Certolizumab Pegol: Results From a Pooled Safety Analysis of 15 Studies: 1831. (October 2015)
Main Title:
Incidence of Benign and Malignant Neoplasms in Crohn's Disease Patients Aged ≤30 Years Versus 30‐64 Years Treated With Certolizumab Pegol: Results From a Pooled Safety Analysis of 15 Studies